Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4573
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mazzoni, D. | en |
dc.contributor.author | Wheller, L. | en |
dc.contributor.author | Levitt, D. | en |
dc.contributor.author | Lobo, Y. | en |
dc.date.accessioned | 2022-11-07T23:54:11Z | - |
dc.date.available | 2022-11-07T23:54:11Z | - |
dc.date.issued | 2022 | en |
dc.identifier.citation | , 2022 | en |
dc.identifier.other | RIS | en |
dc.identifier.uri | http://dora.health.qld.gov.au/qldresearchjspui/handle/1/4573 | - |
dc.description.abstract | While dupilumab has emerged as a novel targeted systemic treatment for severe AD, efficacy and safety-based data in young children are limited. We discuss the case of a 21-month-old child with severe recalcitrant atopic dermatitis successfully treated with dupilumab.L20168802952022-05-23 <br /> | en |
dc.language.iso | en | en |
dc.relation.ispartof | Pediatric Dermatology | en |
dc.title | Severe atopic dermatitis in a 21-month-old boy successfully treated with dupilumab | en |
dc.type | Article | en |
dc.identifier.doi | 10.1111/pde.14996 | en |
dc.subject.keywords | male | en |
dc.subject.keywords | dupilumab | en |
dc.subject.keywords | drug therapy | en |
dc.subject.keywords | articleatopic dermatitis | en |
dc.subject.keywords | case report | en |
dc.subject.keywords | infant | en |
dc.subject.keywords | clinical article | en |
dc.subject.keywords | human | en |
dc.relation.url | https://www.embase.com/search/results?subaction=viewrecord&id=L2016880295&from=exporthttp://dx.doi.org/10.1111/pde.14996 | | en |
dc.identifier.risid | 428 | en |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
Appears in Sites: | Children's Health Queensland Publications |
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.